证券之星消息，康龙化成(300759)11月18日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司刚收购企业能为企业增加多少利润？康龙化成回复：答：尊敬的投资者您好，本次收购无锡佰翱得生物科学股份有限公司(以下简称“目标公司”)完成后，目标公司将纳入公司合并范围，对公司的经营成果预计将产生积极影响。具体内容详见公司于2025年10月29日披露在巨潮资讯网的《关于收购无锡佰翱得生物科学股份有限公司82.54%股份暨关联交易的公告》。本次交易完成后，目标公司可能面临后续经营管理、人才管理、业务整合等相关风险，公司将督促和指导目标公司积极采取有效措施和对策控制和化解风险，敬请广大投资者注意投资风险。感谢您的关注。为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.